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Abstract Amelogenin is the most abundant matrix pro-
tein in enamel. Proper amelogenin processing by protein-
ases is necessary for its biological functions during
amelogenesis. Matrix metalloproteinase 9 (MMP-9) is
responsible for the turnover of matrix components. The
relationship between MMP-9 and amelogenin during tooth
development remains unknown. We tested the hypothesis
that MMP-9 binds to amelogenin and they are co-expressed
in ameloblasts during amelogenesis. We evaluated the
distribution of both proteins in the mouse teeth using
immunohistochemistry and confocal microscopy. At post-
natal day 2, the spatial distribution of amelogenin and
MMP-9 was co-localized in preameloblasts, secretory
ameloblasts, enamel matrix and odontoblasts. At the late
stages of mouse tooth development, expression patterns of
amelogenin and MMP-9 were similar to that seen in
postnatal day 2. Their co-expression was further confirmed
by RT-PCR, Western blot and enzymatic zymography
analyses in enamel organ epithelial and odontoblast-like
cells. Immunoprecipitation assay revealed that MMP-9
binds to amelogenin. The MMP-9 cleavage sites in ame-
logenin proteins across species were found using bio-
informative software program. Analyses of these data
suggest that MMP-9 may be involved in controlling ame-
logenin processing and enamel formation.
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Introduction
Dental enamel is formed by ameloblasts originally derived
from embryonic oral epithelium. The differentiation of
dental epithelium into functional ameloblasts occurs in
spatial–temporal patterns during tooth development and
these ameloblasts synthesize and secrete enamel matrix
proteins. Amelogenin is the most abundant enamel matrix
protein, accounting for about 90 % of total enamel organic
matrix. This gene was cloned and characterized from the
teeth of bovine, porcine, rat, mouse and human (Snead
et al. 1983; Takagi et al. 1984; Gibson et al. 1991a;
Nakahori et al. 1991; Salido et al. 1992; Bonass et al. 1994;
Hu et al. 1996; Diekwisch et al. 1997). It is synthesized in a
distinct time frame during amelogenesis. In mice, amelo-
genin gene expression was identified in ameloblasts and
enamel matrix from embryonic day 15 to postnatal day
14 (Snead et al. 1988; Couwenhoven and Snead 1994;
Hu et al. 2001; Iacob and Veis 2006). Rat amelogenin
expression was also characterized in teeth from embryonic
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day 18.5 to postnatal day 15 as well as the continuously
erupting incisors at the later stages (Fong et al. 1996; Inage
et al. 1996; Bleicher et al. 1999). In developing hamster
teeth, amelogenin expression was identified in pre-amelo-
blasts, secretory, transition, and early maturation stage a-
meloblasts and in the enamel matrix (Karg et al. 1997). A
similar expression pattern was observed in pig teeth except
for ameloblasts after the transition stage (Wakida et al.
1999). Originally, amelogenin was thought to be expressed
solely by ameloblasts during tooth development (Snead
et al. 1988; Inai et al. 1991; Karg et al. 1997; Hu et al.
2001). Recently, it has been found that this gene is also
expressed in odontoblasts and other tissues (Veis et al.
2000; Oida et al. 2002; Nagano et al. 2003; Papagerakis
et al. 2003; Iacob and Veis 2006; Haze et al. 2007).
Amelogenin plays a critical role in the structural organi-
zation of enamel as well as in mineralization (Deutsch et al.
1995; Bartlett and Simmer 1999). Amelogenin gene
mutations in humans and mice cause amelogenesis im-
perfecta (AI), one of the most common enamel genetic
diseases (Lagerstro¨m et al. 1991; Aldred et al. 1992;
Gibson et al. 2001; Wright et al. 2011).
Large-molecular-mass amelogenin proteins as well as
small-molecular-mass amelogenin polypeptides have been
isolated and characterized in different species teeth during
the process of development and mineralization (Bronckers
et al. 1995; Boabaid et al. 2004). The biochemistry and
biological roles of these different fragments in enamel
formation and biomineralization have been studied (Gibson
et al. 1991b; Le et al. 2007; Warotayanont et al. 2008;
Nakayama et al. 2010; Pugach et al. 2010). It is known that
amelogenin requires processing by proteinases to activate
functional domains (Fincham and Moradian-Oldak 1993).
For instance, matrix metalloproteinase 20 (MMP-20) and
kallikren 4 (Klk4) are expressed in ameloblasts during
amelogenesis and are capable of catalyzing enamel matrix
proteins including amelogenin (Li et al. 1999; Ryu et al.
1999; Bourd-Boittin et al. 2004; Sun et al. 2010; Uskok-
ovic´ et al. 2011). These two proteinases are critical for
enamel matrix processing. MMP-20 and Klk4 gene muta-
tions in humans and mice cause hypomaturation AI
(Caterina et al. 2002; Hart et al. 2004; Kim et al. 2005;
Simmer et al. 2009).
Matrix metalloproteinase 9 (MMP-9), also known as
gelatinase B or type IV collagenase, belongs to a member
of the MMP gene family and is expressed in ameloblasts
and odontoblasts as well as other dental cells during tooth
development (Tja¨derhane et al. 1998; Sahlberg et al. 1999;
Randall and Hall 2002; Goldberg et al. 2003; Palosaari
et al. 2003; Yoshiba et al. 2003; Takahashi et al. 2006;
Paiva et al. 2009; Gomes et al. 2011). This enzyme is
involved in bone resorption and degradation of the base-
ment membrane during tooth development as well as
extracellular matrix (ECM) turnover in association with
tooth eruption (Linsuwanont et al. 2002; Basi et al. 2011).
MMP-9 has a broad range of substrate specificity including
native collagenous and non-collagenous proteins as well as
non-structural ECM components (Vu et al. 1998; Kridel
et al. 2001; Somerville et al. 2003; Nagase et al. 2006).
However, the entire assortment of substrates for the MMPs
has not been fully elucidated. MMP inhibitors were used to
treat mouse tooth germs, resulting in impairment of murine
amelogenesis (Fanchon et al. 2004; Bourd-Boittin et al.
2005). Furthermore, bone deficiency was observed and
osteoblast apopotosis was increased in MMP-9 knock out
mice (Vu et al. 1998). Our previous study showed that
abnormal tooth morphology, immature ameloblast differ-
entiation, and loss of ameloblast polarization occur in
MMP-9 null mice (Yuan et al. 2009, unpublished data).
Although expression of both amelogenin and MMP-9
during tooth development was described, their relationship
in tooth formation has not been observed. In the present
study, we were interested in the interaction between ame-
logenin and MMP-9 as well as comparing the spatial–
temporal distribution of both proteins during mouse tooth
development. We hypothesized that interactions between
amelogenin and MMP-9 as well as developmental changes
in the spatial distribution of these two proteins might exist.
To test these hypotheses, we designed experiments to
examine the binding of MMP-9 to amelogenin. We further
analyzed the distribution of amelogenin and MMP-9 at the
same stages of mouse tooth development. Our studies
indicated that MMP-9 binds to amelogenin and they are
co-expressed in ameloblasts in developing mouse teeth.
Furthermore, computational data analysis indicated that
potential cleavage sites of MMP-9 exist in amelogenin
across different species.
Materials and methods
Animals and tissue preparation
All experimental procedures involving the use of animals
were approved by the University of Texas Health Science
Center at San Antonio (UTHSCSA), TX. ICR mice were
purchased from Harlan-Laboratory Animals Inc. (India-
napolis, IN, USA). The MMP-9 knock out mice were
obtained from the Jackson Laboratory (Bar Harbor, Maine,
USA). For developmental studies, mice with litters of
embryonic stage E18.5 and postnatal days 2, 5 and 7 were
sacrificed. Mouse tissues were dissected and fixed in 4 %
paraformaldehyde overnight. After demineralization in
15 % EDTA, samples were dehydrated in increasing con-
centrations of ethanol, embedded in paraffin, sectioned, and
prepared for immunohistochemistry analysis.
474 J Mol Hist (2012) 43:473–485
123
Cell culture
Mouse odontoblast-like cells (MO6-G3) were grown at
33 C under 5 % CO2 in alpha minimum essential medium
(a-MEM) supplemented with 10 % fetal calf serum,
100 units/ml penicillin/streptomycin, 50 lg/ml ascorbic
acid, and 10 mM Na b-glycerophosphate (Sigma, St.
Louis, MO, USA). The mouse enamel organ epithelial
(EOE-3M) cell line was maintained in Dulbecco’s modi-
fied eagle medium (DMEM) (Gibco, Grand Island, NY,
USA) with 10 % fetal calf serum, 100 units/ml penicillin/
streptomycin, 50 lg/ml ascorbic acid.
RNA preparation and reverse transcription-polymerase
chain reaction (RT-PCR)
Total RNA was extracted from mouse teeth and MO6-G3
and EOE-3M cell lines by using RNA STAT-60 kit (Tel-
Test, Inc. Friendswood, TX, USA), treated with DNase I
(Promega, Madison, WI, USA), and purified with the
RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA). RNA
concentration was determined at an optical density of
OD260. The RNA was transcribed into cDNA by Super-
Script II reverse transcriptase (Invitrogen, Carlsbad, CA,
USA). For PCR analysis, specific primers of mouse ame-
logenin and MMP-9 were synthesized as follows: mouse
amelogenin, forward 50-TGAAGTGGTACCAGAGCA-30
and reverse 50-ACAGGGATGATTTGGTGGTG-30; MMP-
9, forward 50-CAGACCAAGAGGGTTTTCTT-30 and
reverse CTTGTTCACCTCATTTTGGA-30. The PCR
reaction was first denatured at 95 C for 5 min, and then
carried out at 95 C for 30 s, at 55–60 C for 30 s and at
72o C for 60 s for 35 cycles and with a final 10 min
extension at 72 C. Five ll of PCR products were analyzed
using agarose gels and ethidium bromide staining. Cor-
rective DNA was verified by DNA sequencing.
Expression and purification of recombinant proteins
The full-length mouse amelogenin gene was amplified by
PCR using mouse tooth cDNA as a template with primers
adding Xho I and Not I sites for directional ligation into
the expression vector pGEX-6P1 with Xho I and Not I
sites (Amersham Pharmacia Biotech, Piscataway, NJ,
USA) and named pGST196 (amino acids1–196). The
pGST196 expression and purification was performed
according to the manufacturer’s instruction (Amersham
Pharmacia Biotech). The recombinant, untagged murine
amelogenin (rM179, amino acids18–196) was subcloned
into pET11a vector with Ndel and BamH I sites (Nova-
gen, Madison, WI, USA) and termed pET179. This
pET179 vector was kindly provided by Dr. Simmer (The
Department of Biological and Materials Sciences, Uni-
versity of Michigan School of Dentistry, Ann Arbor, MI,
USA). A recombinant amelogenin protein was expressed
and purified as described previously (Simmer et al. 1994).
Recombinant mutant MMP-9 (rMut-MMP-9) construct
was generated as described previously (Xu et al. 2005).
Briefly, to obtain rMut-MMP-9 with intact ligand-binding
properties but without catalytic activities, the active site
Glu402 of proMMP-9 was substituted for alanine residue
to generate MMP-9E402A (Morgunova et al. 1999). The
point mutation was introduced into the coding DNA by
overlap-extension PCR using the following primer pairs:
forward, 50-GTGGCGGCGCATGCGTTCGGCCACGCG-
30, and reverse, 50-CGCGTGGCCGAACGCATGCGCCG
CCAC-30. The expression construct for MMP-9 in pRS-
ETA vector served as a template in PCR reaction buffer
that includes 5 ll of 109 reaction buffer, 100 ng of
template DNA, 125 ng of each primer, 25 lM dNTP
mixtures, and 2.5 units Pfu Turbo DNA polymerase. The
cycles included 95 C for 2 min, then 95 C for 30 s,
55 C for 1 min and 72 C for 10 min for 12 cycles.
Subsequently, 1 ll of the DpnI restriction enzyme was
added for 1 h at 37 C to digest the parental DNA.
The pRESTA vector containing histidine tagged rMut-
MMP-9 gene was transformed into E. coli BL21 (DE3)
competent cells and expressed and purified. A recombi-
nant mouse MMP-9 protein was purchased from R&D
Systems Inc. (Minneapolis, MN, USA; Catalog No.
909-MM).
Glutathione fusion protein (GST) pull down assay
For probing protein–protein interactions, either the full
length recombinant amelogenin protein tagged with GST
(pGST196) or GST protein was incubated with the
recombinant mutant MMP-9 protein in the lysis buffer
(20 mM Tris–HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA)
overnight at 4 C with end–over-end mixing. After the
reaction, the glutathione agarose beads were added for
further incubation. The samples were then centrifuged and
the supernatant was removed. After extensive washes, the
beads were mixed with an equal volume of 29 SDS-PAGE
gel-loading buffer and then boiled for 4 min followed by
SDS-PAGE and Western Blot analyses.
Western blot analysis
The proteins were loaded onto a 10 % SDS-PAGE gel
and transferred to a trans-blot membrane (Bio-Rad Lab-
oratory, Inc., Hercules, CA, USA). Western blotting
assay was carried out as described earlier (Chen et al.
2008).
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Gelatin zymography
Gelatinase activity of MO6-G3 and EOE-3M cells was
determined by SDS-PAGE electrophoresis zymography.
The supernatant of MO6-G3 and EOE-3M without serum
treatment underwent electrophoresis without reduction on
SDS-PAGE gels prepared with 7 % acrylamide contain-
ing 0.1 % gelatin. The SDS was removed by a 1-h
incubation in 2.5 % Triton X-100, and the gels were then
incubated in 30 mM Tris–HCl (pH 7.4), 200 mM NaCl,
5 mM CaCl2, and 1 mM ZnCl2 at 37 C for overnight
prior to being stained with Coomassie Brilliant Blue.
Enzyme activity was visualized as zones of gelatin
clearance.
Immunohistochemistry
Primary antibodies including a goat polyclonal anti-Amel
(C-19), a rabbit polyclonal anti-Amel (FL-191), a goat
polyclonal anti-MMP-9 (C-20) and a rabbit polyclonal
anti-MMP-9 (H-129) were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA, USA). The IHC
experiments were performed using an ABC kit (Vector
Laboratories Inc. Burlingame, CA, USA), according to the
manufacturer’s instructions. Either pre-immune rabbit or
goat IgG instead of the first antibodies was used as a
negative control (Dakocytomation, Carpinteria, CA, USA).
For observation of co-expression of amelogenin and MMP-
9, the double-labeled immunostaining was carried out
using two types of primary antibodies along with two types
of fluorescent secondary antibodies. The tissue section was
blocked with normal donkey serum (Sigma, St. Louis, MO,
USA) for 60 min at room temperature and then incubated
with one type of the primary goat polyclonal anti-amelo-
genin antibody, C-19, which was recognized by the donkey
anti-goat secondary antibody conjugated with Alexa Fluo
488 (Molecular Probes, Eugene, OR, USA) followed by
incubation with a rabbit polyclonal antibody against MMP-
9, H-129, recognized by the donkey anti-rabbit secondary
antibody conjugated with Alexa Fluo 568. The immuno-
stained section using the two types of antibodies was
observed under the same parameters in a Nikon inverted
microscope and quantitated by means of NIS-GIEMENTS
software. For each experiment, all slides were simulta-
neously processed for a specific antibody, so that homo-
geneity in the staining procedure was ensured between the
samples. After the capture of these images at the same
magnification, the threshold was set and maintained for
each slide in the experiment. The optical density was cal-
culated by use of the morphometric analysis within the
software package. Hoechst was used for nucleus staining
and either normal rabbit or goat immunoglobulin (IgG)
served as a negative control (Dakocytomation).
Confocal microscopic evaluation and image acquisition
Sections were evaluated with a Nikon Eclipse 90i C1si
laser scanning confocal microscope (Nikon Instruments,
Melville, NY, USA) with a 40X/1.30 N.A. oil immersion
objective. This evaluation included the selection of a laser
gain setting used to image Nav1.6-immunofluorescence to
avoid saturated pixels so to allow a full dynamic range of
Nav1.6-immunofluorescence pixel intensity and to select
laser gain settings used to image caspr staining.
Protein sequencing and data analyses
A database search was performed at the National Center for
Biotechnology Information website (http://www.ncbi.nlm.
nih.gov/blast) using the BLAST program. The amelogenin
nucleotides and derived amino acids were aligned with
those from different species using the Gene Runner soft-
ware program (http://www.generunner).
Results
Expression of amelogenin and MMP-9 in mouse teeth
To determine the expression of the two genes in amelo-
blasts, we systematically evaluated the expression of
amelogenin and MMP-9 in developing mouse teeth using
immunohistochemistry assays. Amelogenin epitopes were
highly localized in the pre-ameloblasts, secretory amelo-
blasts and enamel matrix at the postnatal day 2 (PN2) in
mouse molars (Fig. 1b–d). MMP-9 expression overlapped
with amelogenin in these regions and its signal was also
present in the dental pulp cells, alveolar bone mesenchymal
cells and stratum intermedium (Fig. 1e–g). At PN 5,
amelogenin protein in secretory ameloblasts and enamel
layer was strongly expressed, but low levels of expression
were observed in odontoblasts and stratum intermedium
(Fig. 2b–d). The spatial distribution pattern of MMP-9 was
similar to amelogenin besides its expression in alveolar
bone mesenchyme (Fig. 2f–h). Similar to PN 5, at PN7,
amelogenin was highly expressed in secretory ameloblasts
and enamel in developing molars, whereas its signal was
weakly detected in odontoblasts (Fig. 3b–d). Compared to
amelogenin, the MMP-9 gene was widely expressed
although MMP-9 was also present in ameloblasts and od-
ontoblasts (Fig. 3f–h).
To further study the co-expression of the two proteins in
ameloblasts, their distribution profiles in developing mouse
476 J Mol Hist (2012) 43:473–485
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teeth were examined using double labeling immunohisto-
chemistry. Amelogenin protein in secretory ameloblasts
was strongly expressed, and the signal intensity per cell
was higher in enamel matrix (Fig. 4b, f). This protein in
secretory ameloblasts was mostly located in the supranu-
clear area (towards the enamel), but was also present in the
infranuclear region (away from the enamel). Amelogenin
expression was also detected in odontoblasts, but its
expression level in odontoblasts was much lower than a-
meloblasts and the enamel layer. MMP-9 signal coincided
with the expression of amelogenin in ameloblasts, enamel
layer as well as odontoblasts (Fig. 4c, g). However, the
MMP-9 expression pattern was widely detected in other
tissues besides ameloblasts, enamel matrix and odonto-
blasts. To further confirm their co-localization, tissue sec-
tions from PN4 were examined using the confocal
microscope. The data showed that their co-expression
was seen mostly within the cytoplasm of the ameloblasts
(Fig. 4j).
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Fig. 1 Amelogenin and MMP-9 expression patterns at postnatal day
2 in developing teeth. b Amelogenin expression was observed in pre-
ameloblasts, ameloblasts, enamel matrix and odontoblasts at postnatal
day 2 in mouse molars. c, d were higher magnification of the boxed
area in b. a Pre-immune IgG at the same concentration as anti-
amelogenin antibody was used as a negative control. e Mouse molar
was stained with anti-MMP-9 antibody. f, g show higher magnifica-
tion of the boxed area in e. MMP-9 was widely expressed in bone
mesenchymal cells, stratum intermedium, dental pulp, odontoblasts,
ameloblasts and enamel matrix. i The section was stained with pre-
immune IgG as a negative control. h A tissue section from a MMP-9
knock out mouse was incubated with anti-MMP-9 antibody as
control. Am ameloblasts, D dentin, E enamel, Od odontoblasts, Ob



















Fig. 2 Amelogenin and MMP-9 expression patterns at postnatal day
5 in developing teeth. b Expression of amelogenin protein was found
in ameloblasts, enamel matrix and odontoblasts. c, d were higher
magnification of the boxed area in b. a Pre-immune IgG at the same
concentration as the anti-amelogenin antibody was used as a negative
control. f Immunostaining indicated that MMP-9 was widely
expressed in ameloblasts, odontoblasts and enamel matrix and other
cells. g, h showed higher magnification of the boxed area in f. e Tissue
section was incubated with pre-immune IgG as control. Am amelo-
blasts, D dentin, E enamel, Od odontoblasts, Ob bone mesenchymal
cells, Si stratum intermedium
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Expression of amelogenin and MMP-9 in mouse
enamel organ epithelial and odontoblast-like cells
To assess amelogenin and MMP-9 expression in EOE-3M
and MO6-G3 cells, RT-PCR analysis was performed using
specific primers for amelogenin and MMP-9. Figure 5a
showed that amelogenin and MMP-9 RNAs were identified in
mouse tooth tissues, EOE-3M and MO6-G3 cells. Further-
more, their protein expression was detected by Western blot
and enzymatic zymography assays, respectively (Fig. 5b, c).
Immunohistochemical analysis demonstrated that those
proteins were expressed within the cytoplasm and cellular
branches in EOE-3M and MO6-G3 cells (Fig. 4d–o).
MMP-9 binds to amelogenin in vitro
To determine binding of amelogenin to MMP-9, the
recombinant amelogenin proteins from pET179 and
pGST196 vectors were expressed in E.coli BL21 (DE3)
cells. The crude extracts from sonicated cells were ana-
lyzed by SDS-PAGE to verify protein expression (Fig. 6a).
The SDS-PAGE gel showed that the recombinant proteins,
pET179 and pGST196, appeared at about 25 and 52 kDa,
respectively. There was little sign of amelogenin expres-
sion in the un-induced cells. Following purification with
glutathione beads of the pGST196 fusion protein, the
recombinant amelogenin was resolved to near homogeneity
as analyzed by SDS-PAGE gel (Fig. 6b) and further con-
firmed by Western blot analysis (Fig. 6c). For in vitro
binding analysis, beads bearing either GST or pGST196
fusion protein were mixed with recombinant mutant MMP-
9 protein. After binding and washing, bound proteins were
eluted from the beads. The eluted proteins were separated
by a SDS-PAGE gel and electrotransferred to a trans-blot
membrane for Western blotting assay. These results
showed that beads bearing GST-amelogenin protein pulled
down MMP-9, whereas beads bearing GST alone failed to
bind to MMP-9 protein (Fig. 6d, e). This result indicates
that the amelogenin binds MMP-9 in vitro.
Prediction of MMP-9 cleavage site(s) in amelogenin
Using computer software program, we searched for
potential cleavage site(s) of MMP-9 in amelogenin across
different species. The results show that the MMP-9 scissile






















Fig. 3 Amelogenin and MMP-9 expression patterns at postnatal day
7 in developing teeth. Both amelogenin and MMP-9 were expressed
in ameloblasts, enamel matrix and odontoblasts. b. Tissue section was
stained with anti-amelogenin antibody. c, d showed higher magnifi-
cation of the boxed area in b. Expression of amelogenin was detected
in ameloblasts and the enamel matrix. Also, low levels of amelogenin
were found in odontoblasts. a Negative control. f Immunostaining
indicated that MMP-9 was widely expressed in other cells besides
ameloblasts, odontoblasts and the enamel matrix. g, h showed higher
magnification of the boxed area in f. e Tissue section was incubated
with pre-immune IgG as a negative control. Am ameloblasts, D dentin,
E enamel, Od odontoblasts
Fig. 4 Co-expression of amelogenin and MMP-9 in developing teeth.
Amelogenin expression was detected in pre-ameloblasts, ameloblasts,
enamel matrix and odontoblasts. However, the highest level of
expression was in secretory ameloblasts and the enamel layer (b, f, i).
Amelogenin protein was mostly located within the supra-nuclear area
(towards the enamel) in secretory ameloblasts. MMP-9 was also
expressed in these areas overlapped with amelogenin (c, g, i). d,
h The cells were stained with Hoechst for the nucleus. i Image was
merged. Bar = 10 lM. j Confocal micrographs of collapsed z-pro-
jection images (consisting of 20 z-sections with spacing increments of
1 mM) show amelogenin (green color) and MMP-9 (red color)
staining relationships within ameloblastic cells and enamel matrix of
a tooth section from a postnatal day 4. a0, b0. Higher magnification of
the boxed area in j-a, b: amelogenin expression was weakly detected
in pre-ameloblasts at the cervical loop (Cp) region, but MMP-9
expression (red color) was seen within the cytoplasm in pre-
ameloblasts. Co-expression of amelogenin and MMP-9 proteins was
visible within the cytoplasm of ameloblasts and in the enamel layer.
High expression of amelogenin was observed in secretory ameloblasts
(Am) and enamel matrix (E)
c
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Discussion
Although amelogenin and MMP-9 expression during tooth
development was described (Snead et al. 1988; Diekwisch
et al. 1997; Sahlberg et al. 1999; Linsuwanont et al. 2002;
Goldberg et al. 2003), their co-expression patterns during
mouse tooth development and the interaction between the
two proteins have not been investigated. In the present
study, we investigated the spatial distribution of amelo-
genin and MMP-9 during mouse tooth development using
immunohistochemistry assays. Also, we tested the inter-
action between amelogenin and MMP-9. Our results
showed that the spatial distribution of amelogenin and
MMP-9 is co-localized in ameloblasts, enamel matrix and
odontoblasts during mouse tooth development although
their expression levels and temporal expression patterns
sometimes varied during tooth morphogenesis. Further-
more, amelogenin is able to bind MMP-9 in vitro and the
MMP-9 cleavage sites exist in amelogenin proteins across
different species.
Amelogenin expression was identified in the enamel
organ of mouse molars as early as the embryonic day 15
(Couwenhoven and Snead 1994) and its expression was
still visible in maturation stage ameloblasts at postnatal day
14 in mouse molars (Hu et al. 2001) whereas MMP-9
signal was found both in the dental epithelium and the
mesenchyme at the bud stage (embryonic day 12) of
developing mouse teeth (Sahlberg et al. 1999; Goldberg
et al. 2003; Yoshiba et al. 2003). At the postnatal stages of
tooth formation, expression of MMP-9 and other MMP
family members were present in the differentiating a-
meloblasts (Yoshiba et al. 2003; Fanchon et al. 2004;
Bourd-Boittin et al. 2005; Paiva et al. 2009). We observed
co-expression of both amelogenin and MMP-9 in pre-
secretory ameloblasts, secretory ameloblasts and odonto-
blasts as well as stratum intermedium at postnatal days 2–7
in mouse molars. Amelogenin accumulation increases with
the gradient of the ameloblast differentiation and reaches
an apparent plateau at the secretory stage. For the MMP-9
gene, its expression overlapped with amelogenin, in addi-
tion to the osteogenic mesenchyme and dental pulp cells.
At postnatal days 5 and 7, the MMP-9 expression profile
was similar to that of PN 2. Low amelogenin expression
levels were present in odontoblasts and stratum interme-
dium cells through the postnatal stages of tooth develop-
ment. This evidence was further verified in mouse enamel
organ epithelial (EOE-3M) and odontoblast-like (MO6-G3)
cells. Previous studies indicated that amelogenin expres-
sion was not detected in odontoblasts and other cell types
(Snead et al. 1988; Inai et al. 1991, 1996; Bleicher et al.
1999; Hu et al. 2001). However, recent studies have shown
that amelogenin expression is present in odontoblastic cells
using in situ hybridization, immunohistochemistry and RT-
PCR analyses (Oida et al. 2002; Papagerakis et al. 2003;
Iacob and Veis 2006). Our results are in agreement with
previous studies by other groups (Oida et al. 2002; Papa-
gerakis et al. 2003; Iacob and Veis 2006). However, the
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Fig. 5 Expression of amelogenin and MMP-9 genes in mouse enamel
organ epithelial and odontoblast-like cells. a RT-PCR analysis of
mRNA expression of amelogenin and MMP-9 genes from mouse
tooth tissues, EOE-3M and MO6-G3 cells. RT-PCR products were
run on a 1.5 % agarose gel and stained with ethidium bromide.
M DNA marker. Lanes 2, 6 are the negative control. The PCR
products are 91 bp for amelogenin (lanes 3–5) and 348 bp for MMP-9
(lanes 7–9), respectively. b Expression of amelogenin protein in
EOE-3M and MO6-G3 cells was performed by using Western blot
analysis. Whole cell lysates were separated on a 10 % SDS–
polyacrylamide gel and electroblotted onto Trans-Blot membranes.
The blot was probed with anti-amelogenin antibody and an arrow
indicates a detected signal. c Gelatin zymography was used to detect
MMP-9 protein. Lanes 1, 2 show recombinant mouse MMP-9 protein
(R&D Systems Inc.). Lanes 3, 4 were supernatant from EOE-3M and
MO6-G3 cells without serum treatment, respectively. Recom MMP-9
indicates a recombinant mouse MMP-9 protein. d–o Expression of
amelogenin and MMP-9 proteins in the EOE-3M and MO6-G3 cells
was analyzed by immunostaining with either primary anti-amelogenin
(f, g, l, m) or anti-MMP-9 antibody (h, i, n, q). Negative control was
shown in d, e, i and k. Both amelogenin and MMP-9 signals were
detected within the cytoplasm and cellular branches in EOE-3M and
MO6-G3 cells
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intermedium cells are not known. Besides co-expression of
amelogenin and MMP-9 in ameloblast and odontoblasts,
we further found that MMP-9 is able to interact with
amelogenin, suggesting that amelogenin is a novel partner
of MMP-9.
The amelogenin protein comprises about 90 % of the
enamel matrix proteins and has a range of molecular
masses due to alternative splicing and proteolytic cleavage.
Proteolytic processing of nascent amelogenin molecules
serves to generate proper amelogenin fragments as enamel
development proceeds (Fincham and Moradian-Oldak
1993; Bartlett and Simmer 1999). Studies have revealed
that the NH2-terminal and COOH-terminal domains of
amelogenin proteins are essential for proper enamel for-
mation (Gibson et al. 1991b; Le et al. 2007; Warotayanont
et al. 2008; Nakayama et al. 2010; Pugach et al. 2010). In
contrast, inappropriate processing of amelogenin by pro-
teinases causes enamel defects (Caterina et al. 2002; Hart
et al. 2004; Kim et al. 2005; Simmer et al. 2009).
MMP-9 is a member of the MMP family and has a broad
range of substrates and mediates extracellular matrix
remodeling (Kridel et al. 2001; Somerville et al. 2003;
Lund et al. 2011). It is involved in normal physiological
processes including bone remodeling and tooth eruption
(Linsuwanont et al. 2002; Basi et al. 2011) and in patho-
logical processes like periodontal disease (Rai et al. 2008;
20 µM 
50 µM 
20 µM 20 µM 
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Silva et al. 2008), dental caries (Chaussain-Miller et al.
2006; Shimada et al. 2009) and cancer invasion (Patel et al.
2011). In MMP-9 null mice, impairment of ossification and
vascularization of the skeletal growth plates was observed
(Vu et al. 1998). Skeletal growth plates of MMP-9 null
mice in a culture system showed a delayed release of an
angiogenic activator, establishing a role for this enzyme in
controlling angiogenesis. Engsig et al. (2000) demonstrated
that MMP-9 is essential for the recruitment of osteoclasts
into developing bone. Our study found that mice lacking
MMP-9 gene exhibit abnormal tooth morphology, imma-
ture ameloblast differentiation, loss of ameloblast polari-
zation and delayed tooth eruption as well as an increased
amelogenin expression during amelogenesis compared to
the wild-type mice (Yuan et al. 2009 and unpublished
data).
Amelogenin has been suggested as a possible substrate
for MMP-9 due to the reciprocal concentrations of ame-
logenin and MMP-9 observed during tooth formation
(Fanchon et al. 2004; Bourd-Boittin et al. 2005). Fanchon
et al. used two MMP inhibitors, Marimastat, a general
MMP inhibitor, or CT1166, a more selective inhibitor of
MMP-2 and MMP-9, and found that when mouse tooth
germs were treated with either Marimastat or CT1166,
gelatinase activity was inhibited, resulting in disturbance of
murine amelogenesis. This suggests that MMP-9 is
involved in amelogenin processing and enamel develop-
ment. However, although MMP-9 interacts with amelo-
genin in vitro and there are potential MMP-9 cleavage sites
in amelogenin genes across species, whether MMP-9, like
MMP20 and KlK4, is capable of catalyzing amelogenin
and its role during amelegenesis needs to be further
investigated.
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Fig. 6 Binding of amelogenin to MMP-9 in Vitro. a Coomassie-
stained SDS-PAGE gel for analysis of expression of untagged
pET179 and pGST196 fusion proteins in DE 3 cells. Lane 1 molecular
weight marker; lane 2 pET179 without 1 mM IPTG induction; lane 3
pET179 with 1 mM IPTG induction; lane 4 pGST196 without 1 mM
IPTG induction; lane 5 pGST196 with 1 mM IPTG induction. All
samples were grown 3 h either with or without 1 mM IPTG induction
after reaching OD600 of 0.6. Arrows show positions of expression of
the recombinant amelogenin proteins. b SDS-PAGE analysis of
purified pET179 (lane 1) and pGST196 (lane 2) fusion proteins from
E. coli. extracts. c Expression of purified pET179 (lane 1) and
pGST196 (lane 2) amelogenin proteins was confirmed by Western
blotting analysis using goat polyclonal anti-amelogenin antibody (C-
19, Santa Cruz Biotechnology Inc.). d, e Either 5 lg of GST-
amelogenin fusion protein (pGST196) or 5 lg of GST protein alone
was mixed with the recombinant mutant MMP-9 protein in binding
buffer (20 mM Tris–HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA) and
followed by adding 20 ll of glutathione-agarose beads for further
incubation. After the binding reaction, the beads were washed twice
with binding buffer and once with washing buffer. Beads were boiled
in 19 SDS loading dye and the samples were divided into equal
aliquots, and the eluted proteins were separated by SDS-PAGE and
electrotransferred to the trans-blot membranes. Western blot assay
was carried out using polyclonal anti-GST antibody (Amersham
Pharmacia Biotech) (d) and polyclonal anti-MMP-9 antibody (Santa
Cruz Biotechnology Inc.) (e)
Table 1 Identification of potential MMP-9 cleavage sites of amelo-








P X X ; Hy
S/T
Kridel et al. 2001
Cow P G Y ; I N Iwase et al. 2003 BAC66108
Frog P G Y ; V N Toyosawa et al.
1998
AAC78135
Guinea P G Y ; I N Cerny 1998 CAA09957
Human P G Y ; I N Salido et al. 1992 AAA51717
Mouse P G Y ; I N Snead et al. 1985 BAA06546
Pig P G Y ; I N Iwase et al. 2003 BAC66111
Rat P G Y ; I N Li et al. 1995 AAB03481
P proline, Hy hydrophobic amino acids, S serine, T threonine,
G glycine, Y tyrosine, I isoleucine, N asparagine, X any amino acids.
Scissile bonds are shown with ;
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